118 related articles for article (PubMed ID: 9495274)
1. Prostaglandin I2 contributes to the vasodepressor effect of baicalein in hypertensive rats.
Takizawa H; DelliPizzi AM; Nasjletti A
Hypertension; 1998 Mar; 31(3):866-71. PubMed ID: 9495274
[TBL] [Abstract][Full Text] [Related]
2. Lipoxygenase-dependent mechanisms in hypertension.
DelliPizzi A; Guan H; Tong X; Takizawa H; Nasjletti A
Clin Exp Hypertens; 2000 Feb; 22(2):181-92. PubMed ID: 10744358
[TBL] [Abstract][Full Text] [Related]
3. Expression of prostaglandin H2-mediated mechanism of vascular contraction in hypertensive rats. Relation to lipoxygenase and prostacyclin synthase activities.
Lin L; Balazy M; Pagano PJ; Nasjletti A
Circ Res; 1994 Feb; 74(2):197-205. PubMed ID: 8293559
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin I2 does not contribute to the hypotensive effect of the superoxide dismutase mimetic Tempo in rats with aortic coarctation-induced hypertension.
DelliPizzi A; Guan H; Dinocca S; Nasjletti A
Clin Exp Hypertens; 2004 Apr; 26(3):191-8. PubMed ID: 15132297
[TBL] [Abstract][Full Text] [Related]
5. PGI2-specific antibodies administered in vivo suggest against a role for endogenous PGI2 as a circulating vasodepressor hormone in the normotensive and spontaneously hypertensive rat.
Pace-Asciak CR; Carrara MC; Levine L; Nicolaou KC
Prostaglandins; 1980 Dec; 20(6):1053-60. PubMed ID: 7010446
[TBL] [Abstract][Full Text] [Related]
6. Renovascular actions of angiotensin II in the isolated kidney of the rat: relationship to lipoxygenases.
Bell-Quilley CP; Lin YS; Hilchey SD; Drugge ED; McGiff JC
J Pharmacol Exp Ther; 1993 Nov; 267(2):676-82. PubMed ID: 8246141
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide and the depressor response to angiotensin blockade in hypertension.
Guan H; Cachofeiro V; Pucci ML; Kaminski PM; Wolin MS; Nasjletti A
Hypertension; 1996 Jan; 27(1):19-24. PubMed ID: 8591882
[TBL] [Abstract][Full Text] [Related]
8. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
[TBL] [Abstract][Full Text] [Related]
9. Effects of phospholipase A2, 12-lipoxygenase, and cyclooxygenase inhibitors in the feline pulmonary bed.
Kaye AD; Nossaman BD; Smith DE; Ibrahim IN; Imig JD; Kadowitz PJ
Am J Physiol; 1997 Apr; 272(4 Pt 1):L573-9. PubMed ID: 9142927
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II-induced hypertension in the rat. Effects on the plasma concentration, renal excretion, and tissue release of prostaglandins.
Diz DI; Baer PG; Nasjletti A
J Clin Invest; 1983 Aug; 72(2):466-77. PubMed ID: 6575977
[TBL] [Abstract][Full Text] [Related]
11. Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats.
Blanco-Rivero J; Cachofeiro V; Lahera V; Aras-Lopez R; Márquez-Rodas I; Salaices M; Xavier FE; Ferrer M; Balfagón G
Hypertension; 2005 Jul; 46(1):107-12. PubMed ID: 15956108
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II/prostaglandin I2 interactions in spontaneously hypertensive rats.
Jackson EK; Herzer WA
Hypertension; 1993 Nov; 22(5):688-98. PubMed ID: 8225529
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II-induced contractions in human internal mammary artery: effects of cyclooxygenase and lipoxygenase inhibition.
Stanke-Labesque F; Devillier P; Bedouch P; Cracowski JL; Chavanon O; Bessard G
Cardiovasc Res; 2000 Aug; 47(2):376-83. PubMed ID: 10946074
[TBL] [Abstract][Full Text] [Related]
14. The vasodepressor action of prostacyclin (PGI2) and its effect on plasma angiotensin II and vasopressin in unanaesthetized normotensive and hypertensive rats.
Casals-Stenzel J; Morton JJ
Clin Exp Hypertens (1978); 1979; 1(5):577-96. PubMed ID: 391517
[TBL] [Abstract][Full Text] [Related]
15. 12-Lipoxygenase products modulate calcium signals in vascular smooth muscle cells.
Saito F; Hori MT; Ideguchi Y; Berger M; Golub M; Stern N; Tuck ML
Hypertension; 1992 Aug; 20(2):138-43. PubMed ID: 1639455
[TBL] [Abstract][Full Text] [Related]
16. Renal oxygenases: differential contribution to vasoconstriction induced by ET-1 and ANG II.
Oyekan A; Balazy M; McGiff JC
Am J Physiol; 1997 Jul; 273(1 Pt 2):R293-300. PubMed ID: 9249563
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
18. Arthur C. Corcoran Memorial Lecture. The role of eicosanoids in angiotensin-dependent hypertension.
Nasjletti A
Hypertension; 1998 Jan; 31(1 Pt 2):194-200. PubMed ID: 9453302
[TBL] [Abstract][Full Text] [Related]
19. Enhanced formation of PGI2, a potent hypotensive substance, by aortic rings and homogenates of the spontaneously hypertensive rat.
Pace-Asciak CR; Carrara MC; Rangaraj G; Nicolaou KC
Prostaglandins; 1978 Jun; 15(6):1005-12. PubMed ID: 358292
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of angiotensin II-mediated vasoconstriction by lipoxygenase blockade.
Stern N; Golub M; Nozawa K; Berger M; Knoll E; Yanagawa N; Natarajan R; Nadler JL; Tuck ML
Am J Physiol; 1989 Aug; 257(2 Pt 2):H434-43. PubMed ID: 2504056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
